Stock Analysis on Net
Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Celgene Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Short-term borrowings and current portion of long-term debt 3.62 0.00 1.33 1.41 1.47 4.48 0.00 0.00 4.41 1.65 1.73 1.78 1.87 0.00 0.00 0.00 4.38 7.68 2.89 3.49 0.61 1.23 6.85
Accounts payable 1.02 0.83 0.90 1.18 0.85 0.88 0.93 1.01 0.83 0.90 0.83 0.88 0.88 0.87 0.85 0.89 0.69 1.15 1.17 1.14 1.20 1.18 1.18
Accrued expenses and other current liabilities 7.17 7.75 7.90 8.42 7.91 7.82 7.73 8.37 7.14 7.85 6.27 7.53 6.90 6.38 5.94 6.09 6.12 7.45 7.71 7.31 6.42 6.83 10.69
Income taxes payable 0.20 0.71 0.19 0.22 0.31 0.10 0.16 0.28 0.17 0.11 0.09 0.15 0.01 0.05 0.06 0.07 0.02 0.06 0.07 0.07 0.09 0.10 0.13
Current portion of deferred revenue 0.11 0.11 0.18 0.21 0.23 0.19 0.20 0.25 0.21 0.19 0.19 0.20 0.23 0.18 0.22 0.22 0.27 0.33 0.16 0.16 0.20 0.21 0.24
Current liabilities 12.11% 9.40% 10.51% 11.43% 10.76% 13.46% 9.01% 9.91% 12.76% 10.69% 9.12% 10.54% 9.90% 7.48% 7.06% 7.28% 11.49% 16.68% 12.00% 12.18% 8.52% 9.56% 19.09%
Deferred revenue, net of current portion 0.04 0.10 0.20 0.21 0.22 0.19 0.10 0.11 0.14 0.10 0.10 0.10 0.11 0.11 0.11 0.11 0.11 0.17 0.16 0.16 0.17 0.18 0.20
Income taxes payable 5.93 5.76 5.93 6.17 7.16 7.08 7.28 8.26 1.48 1.53 1.53 1.50 1.38 1.30 1.26 1.20 1.18 1.73 1.65 1.57 1.61 1.66 1.93
Deferred income tax liabilities 6.90 6.83 7.21 7.76 8.22 8.29 8.04 4.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other non-current tax liabilities 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.94 8.31 8.74 8.97 9.42 9.48 9.70 9.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other non-current liabilities 1.58 1.75 1.90 1.34 1.74 1.66 1.94 1.80 6.08 6.02 6.16 6.31 6.48 6.86 7.36 7.55 15.34 10.55 11.44 12.32 13.46 14.29 10.23
Long-term debt, net of discount, excluding current portion 44.22 50.51 52.55 55.72 57.70 59.07 58.66 52.55 40.57 45.48 47.83 49.09 51.59 53.88 54.95 52.68 52.24 35.25 36.06 36.13 41.07 43.22 33.25
Non-current liabilities 58.67% 64.94% 67.80% 71.20% 75.03% 76.28% 76.02% 67.13% 56.20% 61.44% 64.35% 65.97% 68.98% 71.63% 73.39% 70.84% 68.87% 47.70% 49.30% 50.19% 56.31% 59.35% 45.61%
Total liabilities 70.78% 74.35% 78.31% 82.64% 85.80% 89.74% 85.03% 77.04% 68.96% 72.13% 73.48% 76.50% 78.88% 79.11% 80.45% 78.12% 80.36% 64.38% 61.30% 62.37% 64.83% 68.91% 64.70%
Preferred stock, $.01 par value per share; none outstanding 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, $.01 par value per share 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.03 0.03 0.05 0.05 0.05 0.06 0.06 0.04
Common stock in treasury, at cost -63.67 -67.20 -69.87 -74.23 -76.91 -76.84 -66.40 -67.16 -54.33 -56.32 -57.45 -57.97 -60.29 -59.68 -59.43 -51.94 -49.74 -72.07 -67.52 -61.70 -61.52 -63.05 -73.35
Additional paid-in capital 38.86 40.20 40.86 42.22 43.13 41.37 40.74 45.80 42.87 43.47 44.24 44.07 44.78 43.92 43.79 41.10 39.56 59.15 58.27 56.67 57.55 58.75 70.11
Retained earnings 54.07 52.77 50.76 49.49 48.18 46.06 41.55 43.33 41.41 39.90 38.28 35.87 36.05 35.66 34.18 29.85 27.45 42.53 41.14 37.33 35.72 34.29 37.41
Accumulated other comprehensive income (loss) -0.07 -0.14 -0.09 -0.14 -0.23 -0.36 -0.95 0.95 1.06 0.78 1.42 1.49 0.54 0.94 0.97 2.84 2.34 5.96 6.76 5.28 3.37 1.05 1.10
Stockholders’ equity 29.22% 25.65% 21.69% 17.36% 14.20% 10.26% 14.97% 22.96% 31.04% 27.87% 26.52% 23.50% 21.12% 20.89% 19.55% 21.88% 19.64% 35.62% 38.70% 37.63% 35.17% 31.09% 35.30%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Celgene Corp. current liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q1 2019 to Q2 2019 but then increased from Q2 2019 to Q3 2019 exceeding Q1 2019 level.
Non-current liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Celgene Corp. non-current liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Celgene Corp. total liabilities as a percentage of total liabilities and stockholders’ equity decreased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Celgene Corp. stockholders’ equity as a percentage of total liabilities and stockholders’ equity increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.